TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
18,687
|
5,727
|
21,199 |
| Financial expenses |
22
|
23
|
101 |
| Earnings before taxes |
3,774
|
1,072
|
4,355 |
| Total assets |
9,841
|
5,226
|
8,564 |
| Current assets |
9,841
|
5,221
|
8,557 |
| Current liabilities |
3,595
|
1,223
|
1,155 |
| Equity capital |
6,246
|
4,003
|
7,409 |
| - share capital |
97
|
99
|
106 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.5%
|
76.6%
|
86.5% |
| Turnover per employee |
18,687
|
5,727 | |
| Profit as a percentage of turnover |
20.2%
|
18.7%
|
20.5% |
| Return on assets (ROA) |
38.6%
|
21.0%
|
52.0% |
| Current ratio |
273.7%
|
426.9%
|
740.9% |
| Return on equity (ROE) |
60.4%
|
26.8%
|
58.8% |
| Change turnover |
13,061
|
-14,067
|
-4,669 |
| Change turnover % |
232%
|
-71%
|
-18% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.